Stockreport

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Ironwood Pharmaceuticals, Inc. - Class A  (IRWD) 
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com
PDF – LINZESS® (Iinaclotide) EUTRx prescription demand growth of 13% year-over-year –– Remains on track to complete apraglutide NDA submission in Q1 2025 –– Maintains Full Y [Read more]